Rockefeller Capital Management
HAE icon

Rockefeller Capital Management’s Haemonetics HAE Stock Holding History

Rockefeller Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.5K Sell
526
-365
-41% -$23.4K ﹤0.01% 3472
2026
Q1 		$50.2K Buy
891
+13
+1% +$847 ﹤0.01% 3272
2025
Q4 		$70.4K Buy
878
+870
+10,875% +$58.5K ﹤0.01% 2903
2025
Q3 		$390 Buy
+8
New +$495 ﹤0.01% 4300
2023
Q1 		– Sell
-13
Closed -$1K – 2795
2022
Q4 		$1K Buy
+13
New +$1.04K ﹤0.01% 3689
2022
Q3 		– Sell
-386
Closed -$25K – 4079
2022
Q2 		$25K Buy
386
+333
+628% +$19.7K ﹤0.01% 2618
2022
Q1 		$3K Buy
53
+3
+6% +$163 ﹤0.01% 3501
2021
Q4 		$2K Sell
50
-3
-6% -$183 ﹤0.01% 3539
2021
Q3 		$3K Buy
53
+30
+130% +$1.89K ﹤0.01% 3341
2021
Q2 		$1K Sell
23
-7
-23% -$495 ﹤0.01% 3333
2021
Q1 		$3K Sell
30
-12
-29% -$1.49K ﹤0.01% 3020
2020
Q4 		$4K Buy
+42
New +$4.52K ﹤0.01% 2490
2019
Q4 		– Sell
-70
Closed -$9K – 2114
2019
Q3 		$9K Hold
70
– – ﹤0.01% 1454
2019
Q2 		$8K Buy
70
+50
+250% +$4.92K ﹤0.01% 1312
2019
Q1 		$2K Buy
+20
New +$1.82K ﹤0.01% 1786

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rockefeller Capital Management's HAE Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Haemonetics (HAE) stake by 41% in Q2 2026, selling an estimated $23.4K and leaving 526 shares worth $39.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3472.

Rockefeller Capital Management first reported a position in HAE in Q1 2019 and has held it in 15 quarters since. The position peaked at $70.4K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Rockefeller Capital Management held 526 shares of Haemonetics worth $39.5K as of Q2 2026.
  • Rockefeller Capital Management sold 365 Haemonetics shares in Q2 2026, an estimated $23.4K.
  • Haemonetics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3472 holding.
  • Rockefeller Capital Management first reported a position in Haemonetics in Q1 2019 and has held it in 15 quarters since.
  • Rockefeller Capital Management's Haemonetics position peaked at $70.4K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.